Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in ...

Low- and middle-income countries (LMICs) are undergoing a significant health transformation. While once predominantly ...

Bristol Myers Squibb Co. closed $2.39 below its 52-week high ($61.08), which the company reached on November 11th.

Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out ...

Bristol-Myers Squibb can probably continue to grow for a long time. Its dividend looks to be sustainable at the moment. But ...

We recently published a list of 10 Stocks That Are Close To Becoming Dividend Aristocrats. In this article, we are going to ...

BMS has been among the pharma giants that have bought into AI for drug discovery. In 2021, the company struck a $1.2 billion ...

It's been a challenging past few years for Bristol Myers Squibb (NYSE: BMY). The company's financial results dipped following ...

The moves will affect more than 300 employees across both companies as both firms look to drive growth in the long term.

Despite billions poured into research, new medicines still typically take a decade or more to develop.

There is more to the comparison, and in the sections below, we discuss why we think BMY will outperform JNJ in the next three ...

Kentucky has the highest rate of lung cancer diagnosis and mortality in the nation. Frequent screening leads to earlier ...